AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31060586
Drug: DNA fragments
RxNorm normalized name: palmitoyl fragment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DNA fragments from Lactococcus lactis strain Plasma (LC‐Plasma) with varying CpG motif copy numbers and G + C contents.
Trial: 22692704
Drug: AMG 386
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 386 at 10 mg/kg plus sorafenib 400 mg orally twice daily (arm A)
Trial: 22692704
Drug: AMG 386
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 386 at 3 mg/kg plus sorafenib 400 mg orally twice daily (arm B)
Trial: 22692704
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus sorafenib 400 mg orally twice daily (arm C)
Trial: 18977820
Drug: L-dopa (acute
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-dopa (acute challenge)
Trial: 8062610
Drug: Overnight urinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overnight urinary albumin excretion rate (AER) determined by radioimmunoassay
Trial: 11137810
Drug: 3mg sodium
RxNorm normalized name: glimepiride
DrugBank: Glimepiride (DB00222)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 3mg sodium nitroprusside in 10ml of 5% dextrose solution sprayed on the pedicle (Group I, n=42)
Trial: 11137810
Drug: Half of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Half of the sodium nitroprusside solution sprayed and half injected into the pedicle (Group II, n=44)
Trial: 2902683
Drug: Betaxolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol (10 mg, intravenously)
Trial: 25616355
Drug: Sequential treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential treatment (2.5 years of tamoxifen followed by 2.5 years of exemestane)
Trial: 15149346
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose dialysis
Trial: 15149346
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose dialysis
Trial: 24419017
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation to supraspinatus, posterior deltoid & long head of biceps along with routine physiotherapy and occupational therapy for 5 weeks
Trial: 24419017
Drug: Electrical stimulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrical stimulation to supraspinatus & posterior deltoid along with routine physiotherapy and occupational therapy for 5 weeks
Trial: 22284923
Drug: Intramuscular vitamin
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vitamin A 10,000 IU 3 times weekly from day 2 for a minimum of 2 weeks or until establishment of oral feeding
Trial: 18413705
Drug: CP-316,311 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-316,311 (400 mg twice daily)
Trial: 23032478
Drug: Sertraline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (100 mg daily)
Trial: 10911771
Drug: Efacal (Ca
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efacal (Ca 1.0 g, evening primrose oil 4.0 g, marine fish oil 440 mg)
Trial: 10911771
Drug: Calcium alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium alone (Ca 1.0 g)
Trial: 9192063
Drug: Budesonide (new
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (new topical steroid)
Trial: 19540640
Drug: Atorvastatin, 10
RxNorm normalized name: Amlodipine Besylate-Atorvastatin, 10 mg-80 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin, 10 mg/d
Trial: 8457023
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (100 micrograms sodium selenite daily for 14 weeks)
Trial: 28421334
Drug: Therapeutic drug
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic drug monitoring
Trial: 21368663
Drug: Trimacinolone injection
RxNorm normalized name: Triamcinolone
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trimacinolone injection (TA)
Trial: 14662284
Drug: Vitamin-mineral supplement
RxNorm normalized name: Prenatal Vitamins Oral Tablet [PRENATAL VITAMIN-MINERAL SUPPLEMENT]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin-mineral supplement containing recommended daily allowance (RDA) dosages
Trial: 31571853
Drug: Imidafenacin 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidafenacin 0.2 mg
Trial: 19651872
Drug: RTS,S/AS02D malaria
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RTS,S/AS02D malaria vaccine candidate
Trial: 12241657
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg rifapentine plus 900 mg isoniazid once a week
Trial: 12241657
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg rifampicin plus 900 mg isoniazid twice a week
Trial: 2142731
Drug: Naprosyn 500
RxNorm normalized name: Naprosyn 500mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naprosyn 500 mg b.i.d. for 30 days
Trial: 25871017
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (40 g placebo powder daily for 2 months)
Trial: 8996134
Drug: Clodronate 1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate 1,500 mg
Trial: 8942149
Drug: ofloxacin 400
RxNorm normalized name: ofloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ofloxacin 400 mg daily (BB)
Trial: 8942149
Drug: ofloxacin 800
RxNorm normalized name: Ofloxacin
DrugBank: Ofloxacin (DB01165)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ofloxacin 800 mg daily (CC)
Trial: 8942149
Drug: clofazimine 50
RxNorm normalized name: clofazimine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clofazimine 50 mg daily and 300 mg once in 4 weeks + dapsone 100 mg daily (AA)
Trial: 20569733
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of autologous bone marrow mononuclear cells (BMMC)
Trial: 11918829
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg acetaminophen (paracetamol) 6 times daily for 5 days
Trial: 11918829
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg ibuprofen 6 times daily for 5 days
Trial: 10593430
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin twice daily (mean 20569 IU/day)
Trial: 1755884
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml 0.5% bupivacaine with adrenaline
Trial: 1755884
Drug: 10 ml
RxNorm normalized name: Vial Empty 10 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 ml placebo
Trial: 6612389
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg intravenous lidocaine
Trial: 6612389
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg topical lidocaine
Trial: 27406242
Drug: TIME intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TIME intervention (multicomponent program including rigorous assessment, case conferences, treatment and evaluation of NPS)
Trial: 24949564
Drug: Varenicline (VAR;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Varenicline (VAR; 1 mg twice daily)
Trial: 24733235
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose naltrexone (L-NTX; 25 mg once daily)
Trial: 12872395
Drug: Conventional treatment,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment, treated for 3 months
Trial: 6330643
Drug: Naloxone (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.8 mg in 2 ml vehicle each)
Trial: 31671137
Drug: Caffeine 300
RxNorm normalized name: caffeine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine 300 mg
Trial: 29194531
Drug: Conservative surgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative surgery and Radical rectal surgery
Trial: 24136379
Drug: Dexamethasone 8
RxNorm normalized name: dexamethasone 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 8 mg intravenously 2 to 3 hours prior to surgery (Group A)
Trial: 15680454
Drug: New cell-cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New cell-cultured smallpox vaccine (CCSV)
Trial: 10665784
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen treatment in 10 fractions (total dose of 45 Gy)
Trial: 10665784
Drug: Hyperbaric oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric oxygen treatment in 28 fractions
Trial: 1796125
Drug: N-desmethyladinazolam (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-desmethyladinazolam (all doses)
Trial: 6366027
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy with a mixture of three grass pollen-aqueous extracts (velvet, sweet vernal, and timothy)
Trial: 31677701
Drug: Prolonged elemental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged elemental diet (ED) therapy
Trial: 24533512
Drug: Social skills
RxNorm normalized name: Safety 1st Social Safety Pack KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Social skills treatment based on Cognitive Behaviour Therapy principles
Trial: 17608739
Drug: Buccally positioned
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccally positioned implants
Trial: 17608739
Drug: Lingually positioned
RxNorm normalized name: Nitroglycerin Lingual Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lingually positioned implants
Trial: 15215086
Drug: 12 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg/kg every 12 h for 3 doses and then 15 mg/kg every 48 h for 4 doses (daily dosing)
Trial: 15215086
Drug: 6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg/kg every 12 h for 2 doses and then 6 mg/kg every 24 h for 9 doses (alternate-day dosing)
Trial: 9237963
Drug: Olestra 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olestra 20 g
Trial: 30019170
Drug: Immediate functional
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate functional loading of short implants (6 mm)
Trial: 30019170
Drug: Delayed loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed loading of short implants (6 mm)
Trial: 30019170
Drug: Immediate and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate and delayed loading of short implants (6 mm)
Trial: 28842139
Drug: Low-dose daunorubicin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose daunorubicin (45 to 60 mg/m2)
Trial: 22586902
Drug: intramuscular cycloferon
RxNorm normalized name: Cicloferon
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: intramuscular cycloferon
Trial: 15871639
Drug: Intravenous imipenem
RxNorm normalized name: Imipenem
DrugBank: Imipenem (DB01598)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intravenous imipenem 1g plus cilastatin 1g
Trial: 15871639
Drug: Intravenous meropenem
RxNorm normalized name: Meropenem
DrugBank: Meropenem (DB00760)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous meropenem 1g
Trial: 16520833
Drug: Labetalol (1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (1.2 mg/kg)
Trial: 2908516
Drug: Diazepam (challenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (challenge dose)
Trial: 21773032
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (ritodrine and magnesium)
Trial: 17070175
Drug: Atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 10 mg/d for 12 weeks
Trial: 17070175
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Policosanol + Atorvastatin)
Trial: 6743447
Drug: diamorphine hydrochloride
RxNorm normalized name: Diamorphine hydrochloride
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diamorphine hydrochloride 2 mg
Trial: 2872740
Drug: Carotid endarterectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotid endarterectomy and aspirin therapy
Trial: 26920606
Drug: Aspirin therapy
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin therapy alone
Trial: 25691293
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (palliative therapy)
Trial: 22512632
Drug: Inhaled inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled inactivated Mycobacterium phlei
Trial: 23413910
Drug: Inhaled Seretide
RxNorm normalized name: seractide
DrugBank: Seractide acetate (DB09334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled Seretide
Trial: 19380258
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 2 mL lignocaine
Trial: 19380258
Drug: Intramuscular injection
RxNorm normalized name: rabies, intramuscular injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular injection of 5% hypertonic saline
Trial: 16512941
Drug: Incremental yoghurt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incremental yoghurt consumption (125 g/d)
Trial: 8384733
Drug: Oral vaccine
RxNorm normalized name: RotaTeq Oral Vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vaccine
Trial: 8488716
Drug: Parenteral vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral vaccine
Trial: 2441202
Drug: Captopril (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (mean daily dose 84 mg)
Trial: 28971636
Drug: Paracetamol (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1000 mg)
Trial: 26286324
Drug: Mitii™ training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitii™ training (20 weeks, 30 min per day, six days a week, total dose of 60 hours)
Trial: 21784377
Drug: Rosuvastatin 5
RxNorm normalized name: rosuvastatin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin 5 mg once-weekly (with titration to 10 mg if not at LDL goal at week 4)
Trial: 19270639
Drug: Physiotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy plus mesoglycan 50 mg p.o., twice a day
Trial: 16521017
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution containing a low dose of norepinephrine
Trial: 15753743
Drug: 12 mL/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mL/kg predicted body weight tidal volume
Trial: 9401573
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment, 1.0 IU/kg/day, subcutaneous injections from postnatal day 7 until body weight of 2000 g (postnatal week 7-8)
Trial: 20546516
Drug: Single injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single injection PVB followed by CPVB infusion of 0.1% or 0.2% ropivacaine
Trial: 17915572
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose creatine (60 mg/kg/day)
Trial: 17915572
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose (75 g prior to exercise)
Trial: 11875168
Drug: BUD400 (budesonide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BUD400 (budesonide, 200 microg twice daily via pMDI and NebuChamber)
Trial: 11875168
Drug: FP400 (fluticasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FP400 (fluticasone propionate, 200 microg twice daily via pMDI and Babyhaler)
Trial: 10203139
Drug: 17beta-estradiol (E2)
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 17beta-estradiol (E2) supplementation at 2.30 mg x kg(‐1) x d(‐1) (1.13‐3.42 mg x kg(‐1) x d(‐1)) and progesterone (P) supplementation at 21.20 mg x kg(‐1) x d(‐1) (11.23‐27.36 mg x kg(‐1) x d(‐1))
Trial: 20132529
Drug: Sertraline (50‐100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50‐100 mg/day)
Trial: 29247457
Drug: hMG +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hMG + MPA + CC
Trial: 22626879
Drug: Nucleos(t)ide therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nucleos(t)ide therapy (ETV and ADV)
Trial: 19608838
Drug: Dexamethasone 15
RxNorm normalized name: MENTHOL 200 mg in 20000 mg / CAMPHOR (SYNTHETIC) 200 mg in 20000 mg / DEXAMETHASONE 15 mg in 20000 mg TOPICAL OINTMENT [999 ITCH RELIEF]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 15 mg
Trial: 11220429
Drug: Dexamethasone 10
RxNorm normalized name: dexamethasone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10 mg
Trial: 11234783
Drug: Patient-delivered partner
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-delivered partner medication (PDPM)
Trial: 15235555
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anesthesia with propofol and remifentanil
Trial: 11465522
Drug: Buspirone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone (10 to 30 mg b.i.d.)
Trial: 15989452
Drug: Placebo cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cream and IV fentanyl 0.25 microg/kg with an occlusive dressing
Trial: 15989452
Drug: EMLA cream
RxNorm normalized name: LIDOCAINE 25 mg in 1 g / PRILOCAINE 25 mg in 1 g TOPICAL CREAM [Emla Cream]
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EMLA cream and IV fentanyl 0.25 microg/kg with an occlusive dressing
Trial: 14500150
Drug: Group 3
RxNorm normalized name: Chlamydophila psittaci biogroup 3 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 3 (25 mL 0.25% bupivacaine and piroxicam 20 mg)
Trial: 10909489
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment with supplementary chemotherapy (EEP cycle: Etoposide, Epirubicin, Cisplatin or 5-fluorouracil)
Trial: 10909489
Drug: Operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Operative treatment with supplementary chemotherapy
Trial: 8778851
Drug: Melatonin (MT),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin (MT), 5 mg, 2300 h, D6‐D8
Trial: 6716468
Drug: Brief daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief daily telephone calls
Trial: 31206313
Drug: Simvastatin 80
RxNorm normalized name: simvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 80 mg for 7 days
Trial: 26116695
Drug: Exenatide (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide (5 μg)
Trial: 31124581
Drug: Dexamethasone (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (6 mg/m2/day)
Trial: 31124581
Drug: Prednisolone (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone (60 mg/m2/day)
Trial: 20192935
Drug: Voltaren suppository
RxNorm normalized name: Voltarene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voltaren suppository placed in rectum an hour before biopsy
Trial: 16286517
Drug: Orlistat 120
RxNorm normalized name: orlistat 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orlistat 120 mg three times daily for 24 weeks
Trial: 8608096
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose aspirin (60 mg)
Trial: 2212376
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of benazepril and metoprolol OROS
Trial: 19291356
Drug: Daily multivitamin
RxNorm normalized name: DAILY MULTIVITAMIN TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily multivitamin tablet containing vitamin D(2) 400 IU (10 microg) for 6 months.
Trial: 12768070
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (rHuGH) therapy at a dose of 0.2 IU/kg/BW
Trial: 11152056
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment according to TCM principles (n = 20)
Trial: 8251028
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ranitidine and chlorpheniramine